Back
Cellectar Biosciences Stock Price Chart
Sponsored
CLRB
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
CLRB
Cellectar Biosciences
Last Price:
$0.26
Seasonality Move:
-2.17%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cellectar Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.26 | Buy |
20-day SMA: | 0.92 | Sell |
50-day SMA: | 1.56 | Sell |
200-day SMA: | 2.47 | Sell |
8-day EMA: | 0.38 | Sell |
20-day EMA: | 0.8 | Sell |
50-day EMA: | 1.34 | Sell |
200-day EMA: | 2.15 | Sell |
Cellectar Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 10.15 | Sell |
Chaikin Money Flow: | 3336365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 1.67) | Sell |
Bollinger Bands (100): | (1.28 - 2.36) | Sell |
Cellectar Biosciences Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.28 while CLRB 8-day simple moving average is 0.26, which is a Buy signal.
-
The stock price of CLRB is 0.28 while Cellectar Biosciences 20-day SMA is 0.92, which makes it a Sell.
-
Cellectar Biosciences 50-day simple moving average is 1.56 while CLRB share price is 0.28, making it a Sell technically.
-
CLRB stock price is 0.28 and Cellectar Biosciences 200-day simple moving average is 2.47, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
40
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.28. The Score for CLRB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
11.4M
Price in USD:
0.28
Share Volume:
4.1M
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
0.22
Sell
40
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?The Cellectar Biosciences stock price is 0.28 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.28 while CLRB 8-day exponential moving average is 0.38, which is a Sell signal.
-
The stock price of CLRB is 0.28 while Cellectar Biosciences 20-day EMA is 0.80, which makes it a Sell.
-
Cellectar Biosciences 50-day exponential moving average is 1.34 while CLRB share price is 0.28, making it a Sell technically.
-
CLRB stock price is 0.28 and Cellectar Biosciences 200-day simple moving average is 2.15, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is -0.42, suggesting Cellectar Biosciences is a Sell
-
Cellectar Biosciences Relative Strength Index (RSI) is 10.15, which suggest Cellectar Biosciences is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences is (0.45 - 1.67), which suggest Cellectar Biosciences is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences is (1.28 - 2.36), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.